135 related articles for article (PubMed ID: 11370122)
1. New treatment avenues: oral tolerance--mechanisms and applicability to human diseases.
Krause I; Blank M; Shoenfeld Y
Isr Med Assoc J; 1999 Sep; 1(1):45-9. PubMed ID: 11370122
[No Abstract] [Full Text] [Related]
2. [Oral tolerance].
Tanaka K
Nihon Rinsho; 2005 Apr; 63 Suppl 4():389-94. PubMed ID: 15861686
[No Abstract] [Full Text] [Related]
3. Oral tolerance.
Garside P; Mowat AM
Semin Immunol; 2001 Jun; 13(3):177-85. PubMed ID: 11394960
[TBL] [Abstract][Full Text] [Related]
4. Oral tolerance and its role in clinical disease.
Spiekermann GM; Walker WA
J Pediatr Gastroenterol Nutr; 2001 Mar; 32(3):237-55. PubMed ID: 11345170
[No Abstract] [Full Text] [Related]
5. [Mechanisms and applications of oral tolerance].
Marth T; Kelsall BL; Strober W; Zeitz M
Z Gastroenterol; 1999 Feb; 37(2):165-85. PubMed ID: 10190250
[TBL] [Abstract][Full Text] [Related]
6. [Clonal deletion and clonal anergy as the mechanism of self-tolerance induction].
Ota H; Yanagida H; Dobashi H; Ishida H
Nihon Rinsho; 1997 Jun; 55(6):1331-6. PubMed ID: 9200914
[TBL] [Abstract][Full Text] [Related]
7. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
8. Oral tolerance.
Wu HY; Weiner HL
Immunol Res; 2003; 28(3):265-84. PubMed ID: 14713719
[TBL] [Abstract][Full Text] [Related]
9. New strategies in oral immunotherapy for diabetes prevention.
Muir A; Ramiya V
Diabetes Metab Rev; 1996 Apr; 12(1):1-14. PubMed ID: 8861498
[No Abstract] [Full Text] [Related]
10. Treatment of autoimmune diseases by oral tolerance to autoantigens.
Weiner HL; Miller A; Khoury SJ; Zhang ZJ; al-Sabbagh A; Brod SA; Lider O; Higgins P; Sobel R; Matsui M
Adv Exp Med Biol; 1995; 371B():1217-23. PubMed ID: 7502787
[No Abstract] [Full Text] [Related]
11. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity.
Fleeton M; Contractor N; Leon F; He J; Wetzel D; Dermody T; Iwasaki A; Kelsall B
Ann N Y Acad Sci; 2004 Dec; 1029():60-5. PubMed ID: 15681744
[TBL] [Abstract][Full Text] [Related]
12. Peyer's patch dendritic cells as regulators of mucosal adaptive immunity.
Sato A; Iwasaki A
Cell Mol Life Sci; 2005 Jun; 62(12):1333-8. PubMed ID: 15971108
[TBL] [Abstract][Full Text] [Related]
13. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.
Fowler E; Weiner HL
Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395
[TBL] [Abstract][Full Text] [Related]
14. Peyer's patch dendritic cells capturing oral antigen interact with antigen-specific T cells and induce gut-homing CD4(+)CD25(+) regulatory T cells in Peyer's patches.
Nagatani K; Sagawa K; Komagata Y; Yamamoto K
Ann N Y Acad Sci; 2004 Dec; 1029():366-70. PubMed ID: 15681783
[TBL] [Abstract][Full Text] [Related]
15. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
16. Small intestine Peyer's patches are major induction sites of the Helicobacter-induced host immune responses.
Watanabe N; Kiriya K; Chiba T
Gastroenterology; 2008 Feb; 134(2):642-3. PubMed ID: 18242237
[No Abstract] [Full Text] [Related]
17. Oral tolerance: therapeutic implications for autoimmune diseases.
Faria AM; Weiner HL
Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
[TBL] [Abstract][Full Text] [Related]
18. Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?
Tarner IH; Fathman CG
Nat Clin Pract Rheumatol; 2006 Sep; 2(9):491-9. PubMed ID: 16951704
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.
Karpus WJ; Kennedy KJ; Kunkel SL; Lukacs NW
J Exp Med; 1998 Mar; 187(5):733-41. PubMed ID: 9480983
[TBL] [Abstract][Full Text] [Related]
20. The anatomy of mucosal immune responses.
Garside P; Millington O; Smith KM
Ann N Y Acad Sci; 2004 Dec; 1029():9-15. PubMed ID: 15681738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
